KIST Library Institutional Repository

ABL501, PD-L1 x LAG-3, a bispecific antibody promotes enhanced human T cell activation through targeting simultaneously two immune checkpoint inhibitors, LAG-3 and PD-L1.

Authors

Park, Eunyoung; Kim, Hyunejoo; Sung, Eunsil; Jung, Uijung; Hong, Youngeun; Lee, Hanbyul; Ko, Minkyung; Park, Yoon; Park, Chan Kwon; Kim, Seung Joon; Yoo, Jongman; Lee, Kyung Jin; Kim, Jihyo; Lee, Bo Eun; Won, Jonghwa; Jung, Jaeho

Issue Date

2021-05

Publisher

AMER ASSOC CANCER RESEARCH

Citation

AACR Annual Meeting 2021

ISSN

0008-5472

URI

https://pubs.kist.re.kr/handle/201004/77723

Appears in Collections:

KIST Conference Paper > 2021

Files in This Item:

There are no files associated with this item.

Export

RIS (EndNote)

XLS (Excel)

XML